March 6, 2026
The 340B Drug Pricing Program was enacted in 1992 and necessitates that drug manufacturers offer outpatient drugs to the covered entities eligible to the available program at considerably lower rates. The Health Resources and Services Administration manages the program to enable these organizations to stretch limited federal resources.









